Supplementary Table 7 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

Authors :: Brian C. Betts
Said M. Sebti
Claudio Anasetti
Bruce R. Blazar
Harshani R. Lawrence
Nicholas J. Lawrence
Shernan G. Holtan
Elizabeth M. Sagatys
Michael L. Nieder
Marco L. Davila
Rawan G. Faramand
Lia Perez
Farhad Khimani
Taiga Nishihori
Nelli Bejanyan
Asmita Mishra
Jongphil Kim
Hany Elmariah
Kelly Walton
Joseph Pidala
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: The table shows maximum acute GVHD organ stage and overall grade observed through day +100 after transplant on the PAC/SIR/TAC phase I trial.

Full Text Access

Tools